Last updated: 2026-09-16 13:20:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Rapid Micro Biosystems, Inc. (RPID) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1,17, with a market capitalisation of $58,69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,13 to $4,94. This page covers its latest market performance, valuation, price trends and company information.
$58,69M | |
$1,17 | |
$27,04 | |
$0,58 | |
$1,15 | |
13,00 | |
227,59K | |
-- | |
$4,94 | |
$1,13 | |
-- | |
-- |
Rapid Micro Biosystems, Inc. (RPID) is trading at $1,17 in pre-market trading as of 2026-09-16 12:48:00, up 1,74% ($0,02) from the previous close of $1,15
Pre-market trading shows how investors are pricing RPID before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Rapid Micro Biosystems, Inc. (RPID) moved from $1,31 to $1,17, representing a decline of 10,69% ($0,14).
The stock traded between $1,13 and $1,49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 296,71 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1,0%
RPID is currently trading at $1,17, placing it 1,0% of the way from its 52-week low of $1,13 to its 52-week high of $4,94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 171 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Rapid Micro Biosystems, Inc. (RPID) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.